| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $0.1411 ▲ +4.52% | Yesterday | $0.1355 ▼ -0.37% | Tomorrow's Sangamo Therapeutics Inc. Common Stock (SGMO) setup is anchored to $0.1350 and targets $0.1411 (+4.52%). The near-term read is upside; watch $0.2799 / $0.1323 because daily realized volatility is about 8.00%. |
Tomorrow's Sangamo Therapeutics Inc. Common Stock (SGMO) setup is anchored to $0.1350 and targets $0.1411 (+4.52%). The near-term read is upside; watch $0.2799 / $0.1323 because daily realized volatility is about 8.00%. | ||||
| Week | $0.1498 ▲ +10.96% | Last Week | $0.1150 ▲ +17.39% | The 7-day Sangamo Therapeutics Inc. Common Stock model moves from $0.1150 to $0.1498 (+10.96%). It gives upside momentum context for this stock, so breaks around $0.2799 / $0.1323 matter more than a single tick. |
The 7-day Sangamo Therapeutics Inc. Common Stock model moves from $0.1150 to $0.1498 (+10.96%). It gives upside momentum context for this stock, so breaks around $0.2799 / $0.1323 matter more than a single tick. | ||||
| Month | $0.1620 ▲ +20.00% | Last Month | $0.2620 ▼ -48.47% | The 1-month Sangamo Therapeutics Inc. Common Stock target is $0.1620 (+20.00%), compared with the live reference near $0.1350. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Sangamo Therapeutics Inc. Common Stock target is $0.1620 (+20.00%), compared with the live reference near $0.1350. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $0.1782 ▲ +32.00% | Last Year | $0.4700 ▼ -71.28% | The 1-year Sangamo Therapeutics Inc. Common Stock scenario points to $0.1782 (+32.00%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Sangamo Therapeutics Inc. Common Stock scenario points to $0.1782 (+32.00%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $0.2152 ▲ +59.41% | 5 Years Ago | $10.82 ▼ -98.75% | The 5-year Sangamo Therapeutics Inc. Common Stock view is $0.2152 (+59.41%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Sangamo Therapeutics Inc. Common Stock view is $0.2152 (+59.41%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| RSI 14 | 1.0 | Bearish |
| MACD | 0.10 | Bullish |
| SMA 50 | $0.1388 | Mid |
| SMA 200 | $1.38 | Mid |
| EMA 20 | $1.96 | Mid |
| Opening Price | $0.1300 | Start Date | 2020-01-02 |
| Day Range | $0.1175 – $0.1420 | Market Cap | $106.68M |
| Monthly Range | $0.1011 – $0.2786 | 24h Volume | n/a |
| 90D Range | $0.1011 – $0.5679 | Circulating | n/a |
| 52W Range | $0.1011 – $2.82 | Max Supply | n/a |
| SGMO | MUFG | AXP | AMGN | AZN | HSBC | |
|---|---|---|---|---|---|---|
| SGMO | 1.00 | 0.97 | -0.96 | -0.96 | -0.96 | -0.95 |
| MUFG | 0.97 | 1.00 | -0.99 | -0.99 | -0.99 | -0.96 |
| AXP | -0.96 | -0.99 | 1.00 | 1.00 | 1.00 | 0.99 |
| AMGN | -0.96 | -0.99 | 1.00 | 1.00 | 1.00 | 0.99 |
| AZN | -0.96 | -0.99 | 1.00 | 1.00 | 1.00 | 0.98 |
| HSBC | -0.95 | -0.96 | 0.99 | 0.99 | 0.98 | 1.00 |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.